Clinical outcomes of patients with pemphigus treated by the same physicians in a public safety net healthcare system vs. a private healthcare system

Br J Dermatol. 2019 Oct;181(4):850-852. doi: 10.1111/bjd.17983. Epub 2019 Jul 21.

Authors

M Kasperkiewicz^{1

2}, O Lai¹, A Recke², A Betlachin¹, L Ji³, S Groshen³, D Woodley¹

Affiliations

¹ Department of Dermatology, The Keck School of Medicine, University of Southern California, USC/Norris Cancer Center, Los Angeles, CA, U.S.A.
² Department of Dermatology, University of Lübeck, Lübeck, Germany.
³ Department of Preventive Medicine, University of Southern California, USC/Norris Cancer Center, Los Angeles, CA, U.S.A.

PMID: 30959576
DOI: 10.1111/bjd.17983

No abstract available

Publication types

Comparative Study
Letter

MeSH terms

Dermatologic Agents / therapeutic use*
Disease-Free Survival
Healthcare Disparities / economics
Healthcare Disparities / statistics & numerical data*
Humans
Insurance Coverage / economics
Insurance Coverage / statistics & numerical data
Insurance, Health / economics
Insurance, Health / statistics & numerical data
Kaplan-Meier Estimate
Medication Adherence / statistics & numerical data
Pemphigus / drug therapy*
Pemphigus / mortality
Private Practice / statistics & numerical data*
Recurrence
Retrospective Studies
Safety-net Providers / statistics & numerical data*
Socioeconomic Factors
Time Factors

Substances

Dermatologic Agents